Sigma Planning Corp Veracyte, Inc. Transaction History

Sigma Planning Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 31, 2019	SELL	$9.15 - $14.85 $213,927 - $347,193	-23,380 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$9.55 - $12.64 $1,814 - $2,401	190 Added 0.82%	23,380 $223,000
Q2 2018 Aug 02, 2018	BUY	$5.39 - $9.66 $124,994 - $224,015	23,190 New	23,190 $217,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.